An International Multi-Centre Study Of Anastrozole Versus Placebo In Postmenopausal Women At Increased Risk Of Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Registrational; Therapeutic Use
- Acronyms IBIS-II; IBIS-II-Prevention
- 23 Nov 2015 Results published in the Journal of Clinical Oncology
- 05 Apr 2014 Results for the effect on bone turnover markers presented at the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
- 12 Dec 2013 Results published in the Lancet.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History